Features of the clinical course of cardiovascular pathology on the background of thyrotoxicosis
Abstract
Relevance of the topicofthyroid diseases is duetothein crease in their number in the world and in Ukraine inparticular over the past 5 years, as well as the fact that the total frequency of various forms of thyroid pathology, even outside the zones of endemic goiter, is about 20% of the total morbidity.
On the example of a clinical case, the question of diagnostics, management tactics and features of the clinical course of cardiovascular pathology on the background of thyrotoxicosis in the absence of adequate therapy for a long time are considered.
Thyrotoxicosis leads to the occurrence of early complications of the cardiovascular system, which determine the further prognosis of the patient’s quality of life. The heart effects of Thyrotoxicosisare most dangerous for the elderly, and they (the heart effects of Thyrotoxicosis) often dominate the clinical picture in them (the elderly).
Difficulties in their diagnosis are due, among other things, to the frequent absence of ophthalmopathy. When atrial fibrillation develops, the presence of cardiac symptoms may increase, indicating an accelerated development of heart failure.
Therefore, the management of patients with cardiovascular disease on the background of thyrotoxicosis has its own peculiarities, which should be taken into account during treatment.
Downloads
References
Fadeyev VV. (2017). Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Clinical and experimental thyroidology.;13(3):45-56 [In Russ.]
Marusenko I.M., Petrova E.G. (2017).HYPERTHYROIDISM AND ATRIAL IBRILLATION. Rational Pharmacotherapy in Cardiology;13(3):398-402. [In Russ.]
2018 ESC/ESH Guidelines for the manage ment of arterial hypertension / BryanWilliams Giuseppe Mancia Wilko Spiering Enrico Agabiti Rosei Michel Azizi Michel Burnier Denis L Clement Antonio Coca Giovannide Simone Anna Dominiczak// European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–3104.
2016 ESC Guidelines for the diagnosis and treatmen to facute and chroniche artfailure: The Task Force for the diagnosis and treatmen to facute and chroniche artfailure ofthe European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) ofthe ESC / Piotr Ponikowski Adriaan A Voors Stefan D Anker Héctor Bueno John G F Cleland Andrew J S Coats Volkmar Falk José Ramón González-Juanatey Veli-Pekka Harjola Ewa A Jankowska // European Heart Journal, Volume 37, Issue 27, 14 July 2016, Pages 2129–2200.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC // Eur. Heart J.-2016. – Vol. 37 (27).– P. 2129–2200.
2016 ESC Guidelines for the managemen to fatrial fibrillation developedin collaboration with EACTS / Paulus Kirchh of Stefano Benussi Dipak Kotecha Anders Ahlsson Dan Atar Barbara Casadei Manuel Castella Hans-Christoph Diener Hein Heidbuchel Jeroen Hendriks // European Heart Journal, Volume 37, Issue 38, 7 October 2016, Pages 2893–2962.
P.Kirchhof, S.Benussi, Dipak Kotecha et al. (2016). ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European heart journal, 2016.
